ROSENOW EDWARD C III 4
4 · BIOSANTE PHARMACEUTICALS INC · Filed Apr 2, 2010
Insider Transaction Report
Form 4
ROSENOW EDWARD C III
Director
Transactions
- Award
Non-Statutory Stock Option (right to buy)
2010-03-31+10,000→ 10,000 totalExercise: $1.79From: 2011-03-31Exp: 2020-03-30→ Common Stock (10,000 underlying)
Holdings
- 17,540
Common Stock